Site Editor

William J. Gradishar, MD, FACP, FASCO

Advertisement

Advertisement

News

SITC 2024: Elucidating the Therapeutically Relevant Mechanisms of TROP2 in Breast Cancer

News

SITC 2024: Adding IL-4 Inhibitor to PD-1 Inhibitor Therapy for ER-Positive Breast Cancer

Medical Literature

Duration of Aromatase Inhibition and Coronary Artery Calcification in Patients With Breast Cancer

News

SITC 2024: CRISPR Editing Yields New B-Cell Strategies for Treating HER2-Positive Breast Cancer

Medical Literature

Plant-Derived Extracellular Nanovesicles: Biomedical Approach to Triple-Negative Breast Cancer

News

ASCO Quality 2024: Benefits of Acupuncture in Treating Chemotherapy-Induced Peripheral Neuropathy

News

ASTRO 2024: Noninferiority Trial of Hypofractionated Radiation Schedules After Mastectomy

Cynthia X. Ma, MD, PhD, on Copanlisib, Fulvestrant, and Abemaciclib for HER2-Positive Breast Cancer: New on the Scene

William J. Gradishar, MD, on the Therapeutic Shift in Managing HR-Positive, HER2-Negative Breast Cancer

View More

Advertisement

JNCCN Spotlights

(UPDATE) Fam-Trastuzumab Deruxtecan-nxki

(UPDATE) Talazoparib in Breast Cancer

(UPDATE) Neratinib in Breast Cancer

Fulvestrant

Talazoparib (Breast Cancer)

(UPDATE) Pertuzumab in Breast Cancer

(UPDATE) Ribociclib in Breast Cancer

Fam-trastuzumab Deruxtecan-nxki

View More

More

News

Abemaciclib Plus Endocrine Therapy Under Study in Advanced Breast Cancer

ESMO 2024: Adding SBRT to Immunotherapy and Chemotherapy in High-Risk Breast Cancer

ASTRO 2024: Noninferiority Trial of Hypofractionated Radiation Schedules After Mastectomy

Which Has Fewer Complications: Minimal Access or Conventional Nipple-Sparing Mastectomy?

Insomnia and Inflammation in Breast Cancer Survivors: Tai Chi and Cognitive Behavioral Therapy

Therapeutic Implications of Pathogenic Variants in Metastatic Breast Cancer

Could Manuka Honey Be Beneficial in Treating Estrogen-Positive Breast Cancer?

ESMO 2024: DESTINY-Breast12 Supports T-DXd in Patients With HER2-Positive Breast Cancer and Brain Metastases

View More

Advertisement

Published

Medical Literature

Unlocking the Genetic Complexity of Breast Cancer: Focus on Rare Haplotypes

Predicting Breast Cancer–Related Lymphedema Among Women of Different Races

Connection Between Obesity and Breast Cancer Prognosis: More Data Emerge

Heart of the Matter: Cardiac Rehabilitation After Chemotherapy for Early-Stage Breast Cancer

View More

Ongoing

CE Activities

Keeping the Outcome in Mind: Applying Best Practices for Managing HR+/HER2- EBC at High Risk of Recurrence

Breast Cancer Prevention, Screening, Diagnosis, and Treatment

The Role of Lifestyle and the Environment in Breast Cancer Risk

Recorded Presentations from the NCCN 2023 Breast Cancer Congress With Updates From The 2022 San Antonio Breast Cancer Symposium

View More

Available

Clinical Trials

Older Breast Cancer Patients: Risk for Cognitive Decline

Tomosynthesis Mammographic Imaging Screening Trial (TMIST) EA1151

A Phase II Trial of Avelumab or Hydroxychloroquine with or without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY)

A Randomized Phase II Window-of-opportunity Trial of Ruxolitinib in Patients with High Risk and Premalignant Breast Conditions

View More

Resources

For Your Patients

After Breast Cancer Diagnosis (ABCD)

Breast Cancer Research Foundation

Breastcancer.org

Facing Our Risk of Cancer Empowered

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2024 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.